Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities

Area of Science:

• Ophthalmology and Pharmaceutical Sciences
• Biomedical Engineering and Drug Delivery

Background:

• Glaucoma is a leading cause of irreversible blindness, often asymptomatic until late stages.
• The eye's natural barriers present significant challenges for effective ocular drug delivery.
• Current glaucoma treatments face limitations, necessitating innovative approaches.

Purpose of the Study:

• To review the current landscape of glaucoma treatment modalities.
• To explore the potential of advanced ocular drug delivery systems, particularly nano-pharmaceuticals.
• To identify research gaps for the commercialization of novel nanotechnology-based ocular delivery systems.

Main Methods:

• Literature review of glaucoma etiology, risk factors, and treatments.
• Presentation of existing and investigational ocular drug delivery systems.
• Analysis of nanotechnology-based delivery systems for glaucoma management.

Main Results:

• Smart delivery systems offer potential solutions to challenges in topical ocular drug delivery.
• Nano-pharmaceuticals show promise for improved glaucoma therapies and reduced vision loss.
• A gap analysis highlights necessary investigations for commercializing novel ocular delivery systems.

Conclusions:

• Advanced drug delivery systems, especially nanotechnology-based ones, are crucial for overcoming ocular barriers in glaucoma treatment.
• Further research and development are needed to translate these innovations into clinical practice.
• Targeted and smart delivery systems represent the future of efficient glaucoma management.